Atossa Therapeutics (ATOS) Interest Expenses (2011 - 2015)
Atossa Therapeutics' Interest Expenses came in at $1,784 for Q1 2015, up 138.2% from $749.00 a year earlier but down 86.7% from the prior quarter.
Powered by 
Analysis
Atossa Therapeutics (ATOS) Interest Expenses (2011 - 2015) Analysis & Trends
Over the trailing twelve months to Mar 31, 2015, Atossa Therapeutics reported Interest Expenses of $16,804; for FY2014, it came in at $15,769.
- Interest Expenses carries a three-year compound annual growth rate of -4.3% (FY2011 to FY2014).
- Going back by year, Interest Expenses was $360.00 in FY2013 (-97.0%), $12,040 in FY2012 (-33.1%) and $17,992 in FY2011.
- The five-year range for quarterly Interest Expenses is $1.00 (Q3 2013) to $13,426 (Q4 2014).
- Year-over-year, Interest Expenses increased in two of the last four quarters, with growth averaging 65.6%.
- Business Quant data shows ATOS's Interest Expenses at $13,426 (Q4 2014), $151.00 (Q3 2014) and $1,443 (Q2 2014) in the three quarters before Q1 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 217.00 Mn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | - |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 462.00 Mn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 435.00 Mn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 653.00 Mn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 269.00 Mn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | - |
| 10 | Atossa Therapeutics | 19.96 Mn | -131.01 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2015 | 1,784.00 |
| Dec 31, 2014 | 13,426.00 |
| Sep 30, 2014 | 151.00 |
| Jun 30, 2014 | 1,443.00 |
| Mar 31, 2014 | 749.00 |
| Sep 30, 2013 | 1.00 |
| Jun 30, 2013 | 352.00 |
| Mar 31, 2013 | 7.00 |
| Dec 31, 2012 | 224.00 |
| Sep 30, 2012 | 7,756.00 |
| Jun 30, 2012 | 2,446.00 |
| Mar 31, 2012 | 1,613.00 |
| Dec 31, 2011 | 9,604.00 |
| Sep 30, 2011 | 758.00 |
API Access
Atossa Therapeutics Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-expenses&ticker=ATOS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-expenses", "ticker": "ATOS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-expenses&ticker=ATOS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();